The National Multiple Sclerosis Society has awarded a pilot research grant to the Jewell Research Lab. This grant will support development of a new vaccine strategy for combining biomaterials with lymph node engineering to promote immune tolerance that could help combat multiple sclerosis (MS). The project will harness biomaterials to co-deliver self antigen with tolerizing immune cues that drive self-antigen specific regulatory cells. These cells could specifically control pathogenic self-reactive cells while leaving the rest of the immune system intact. Thanks to the National MS Society for supporting this new approach!
Prof. Jewell chaired a conference session with colleague Ben Keselowsky focused on materials in immunoengineering. The session was held on Thursday at the annual meeting of the Biomedical Engineering Society (BMES) in Seattle, WA. Presentations included exciting results in areas spanning immunomodulation, vaccine design, and immunotherapy. Special thanks to Julia Babensee from Georgia Tech for kicking the session off with an invited talk, and to all the speakers for great science!
Jewell Lab Blog
Check back often for current news, events, and findings